T H M Ottenhoff
Overview
Explore the profile of T H M Ottenhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Leyten E, Prins C, Bossink A, Thijsen S, Ottenhoff T, van Dissel J, et al.
Eur Respir J
. 2007 Jan;
29(6):1212-6.
PMID: 17215314
Recently, interferon-gamma release assays (IGRA) for specific diagnosis of Mycobacterium tuberculosis infection have become available. In recent UK tuberculosis (TB) guidelines, it has been advised to screen for latent M....
22.
Parkash O, Kumar A, Nigam A, Franken K, Ottenhoff T
Scand J Immunol
. 2006 Sep;
64(4):450-5.
PMID: 16970689
The potential of the recombinant serine-rich 45-kDa antigen (ML0411) of Mycobacterium leprae to aid in detecting M. leprae-specific serum antibodies was assessed by an enzyme-linked immunosorbent assay (ELISA) in leprosy...
23.
Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, Istriana E, et al.
Int J Tuberc Lung Dis
. 2006 Jun;
10(6):696-700.
PMID: 16776459
Setting: Diabetes mellitus is a known risk factor for tuberculosis (TB), but no studies have been reported from South-East Asia, which has a high burden of TB and a rapidly...
24.
Fortes A, Pereira K, Antas P, Franken C, Dalcolmo M, Ribeiro-Carvalho M, et al.
Clin Exp Immunol
. 2005 Jul;
141(3):541-8.
PMID: 16045745
Multidrug-resistant tuberculosis (MDR-TB) is known as having a poor prognosis with a weak response to therapy and very high death rates. The aim of this work was to assess the...
25.
Antas P, Cardoso F, Pereira K, Franken K, Cunha K, Klatser P, et al.
Trans R Soc Trop Med Hyg
. 2005 Jul;
99(9):699-707.
PMID: 15993451
Production of IFN-gamma guarantees helpful T cell-mediated immunity against Mycobacterium tuberculosis infection. We have evaluated the in vitro immune responses to M. tuberculosis antigens using IFN-gamma production among 43 Brazilian...
26.
Moraes M, Pacheco A, Schonkeren J, Vanderborght P, Nery J, Santos A, et al.
Genes Immun
. 2004 Aug;
5(7):592-5.
PMID: 15306847
We have determined IL-10 promoter genotypes of five single-nucleotide polymorphisms (SNPs): T-3575A, A-2849G, C-2763A, -A-1082G and C-819T. The haplotype frequencies were defined in healthy subjects compared to leprosy patients, and...
27.
Arend S, Cerda de Palou E, de Haas P, Janssen R, Hoeve M, Verhard E, et al.
Clin Microbiol Infect
. 2004 Aug;
10(8):738-48.
PMID: 15301677
The clinical and epidemiological characteristics of 17 patients diagnosed with Mycobacterium kansasii pneumonia within a limited geographical region over a period of 10 years are described. An in-depth evaluation of...
28.
Bayley J, Ottenhoff T, Verweij C
Genes Immun
. 2004 Feb;
5(5):315-29.
PMID: 14973548
The in vitro study of TNF promoter polymorphism (SNP) function was stimulated by the numerous case-control (association) studies of the polymorphisms in relation to human disease and the appearance of...
29.
Geluk A, van Meijgaarden K, Franken K, Wieles B, Arend S, Faber W, et al.
Scand J Immunol
. 2004 Jan;
59(1):66-70.
PMID: 14723623
Mycobacterium tuberculosis culture filtrate protein-10 (CFP-10) (Rv3874) is considered a promising antigen for the immunodiagnosis of tuberculosis (TB) together with early secreted antigens of M. tuberculosis (ESAT-6). Both ESAT-6 and...
30.
Lammas D, de Heer E, Edgar J, Novelli V, Ben-Smith A, Baretto R, et al.
Int J Exp Pathol
. 2002 Jun;
83(1):1-20.
PMID: 12059906
Patients with genetic lesions in the Type-1 cytokine/cytokine receptor pathway exhibit a selective susceptibility to severe infections with poorly pathogenic mycobacteria and non-typhi salmonella spp. These experiments of nature demonstrate...